Investing.com -- Following Donald Trump's recent election victory, JPMorgan (NYSE:JPM)'s quantitative analysts anticipate ...

In a recent interview, J.P. Morgan CEO Jamie Dimon expressed growing concerns about what’s happening in the world today, ...

As more wealthy empty nesters stick to the North Shore rather than move to the Loop, the banking giant says they're looking ...

In celebration of its 100th year as an institution open to the public, the Morgan Library and Museum has launched the ...

On Tuesday, bluebird bio Inc (BLUE) stock saw a decline, ending the day at $0.39 which represents a decrease of $-0.02 or -4.88% from the prior close of $0.41. The stock opened at $0.4 and touched a ...

Belite Bio, Inc. ( NASDAQ: BLTE) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Tom Lin - Chairman and Chief Executive Officer Hendrik Scholl - Chief Medical Officer Nathan Mata - Chief ...

JP Morgan has recently reduced bluebird bio Inc (BLUE) stock to Neutral rating, as announced on August 15, 2024, according to Finviz. Earlier, on December 11, 2023, HSBC Securities had reduced the ...

Morgan Stanley co-head Jacques Chappuis will replace David Hunt as PGIM's CEO in May, taking over the global asset management ...

ET Net News Agency, 11 November 2024] IMMUNEONCO-B (01541) rose 11.9% to HK$8.34, breaking above the 10-D SMA of HK$7.606. It hits an intra-day high of HK$8.34, and an intra-day low of HK$7.15. The ...

The first two years under Donald Trump’s second term could be “quite impactful” if policy changes are made on tax, ...

J.P. Morgan analyst Eric Joseph maintained a Buy rating on Rocket Pharmaceuticals (RCKT – Research Report) yesterday and set a price ...

J.P. Morgan analyst Anupam Rama maintained a Buy rating on Neurocrine (NBIX – Research Report) on November 6 and set a price target of ...